(Q45872607)

17 December 2017

title

Hyperhomocysteinemia in women with advanced breast cancer (English)

1 reference

17 December 2017

author name string

Gatt A

1

1 reference

17 December 2017

Makris A

2

1 reference

17 December 2017

Cladd H

3

1 reference

17 December 2017

Burcombe RJ

4

1 reference

17 December 2017

Smith JM

5

1 reference

17 December 2017

Cooper P

6

1 reference

17 December 2017

Thompson D

7

1 reference

17 December 2017

Makris M

8

1 reference

17 December 2017

publication date

1 December 2007

1 reference

17 December 2017

International Journal of Laboratory Hematology

published in

1 reference

17 December 2017

volume

29

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

421-425

1 reference

17 December 2017

Tamoxifen reduces plasma homocysteine levels in healthy women

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: the Tehran homocysteine survey (2003-2004)/a cross-sectional population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Parsing an enigma: the pharmacodynamics of aspirin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Investigation of systemic folate status, impact of alcohol intake and levels of DNA damage in mononuclear cells of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Red blood cell methylfolate and plasma homocysteine as risk factors for venous thromboembolism: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Hemostatic alterations in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Children with acute lymphoblastic leukaemia have high plasma levels of total homocysteine at time of diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Genetic and plasma markers of venous thromboembolism in patients with high grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Increase in plasma homocysteine levels induced by drug treatments in neurologic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Plasma total homocysteine levels in a healthy Turkish population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Homocysteine inhibits inactivation of factor Va by activated protein C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-553X.2007.00907.X

10.1111/J.1751-553X.2007.00907.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

17988296

1 reference

17 December 2017